Can You Take Dramamine with Linzess?
Yes, you can take Dramamine (dimenhydrinate) with Linzess (linaclotide) as there are no known drug interactions between these medications.
Why These Medications Don't Interact
Linzess works locally in the gastrointestinal tract with negligible systemic absorption—plasma concentrations are below the limit of quantitation after oral administration 1. The drug is metabolized entirely within the GI tract and broken down into smaller peptides and amino acids 1.
Because linaclotide has essentially no systemic exposure:
- It does not interact with cytochrome P450 enzymes
- It does not interact with common drug transporters (including P-glycoprotein)
- No drug-drug interaction studies have been conducted because systemic drug interactions are not anticipated 1
Dramamine (dimenhydrinate), an antihistamine that works systemically for nausea and motion sickness, would therefore have no pharmacokinetic or pharmacodynamic interaction with linaclotide.
Important Clinical Considerations
Timing of Administration
- Take Linzess on an empty stomach at least 30 minutes before your first meal 1
- Dramamine can be taken with or without food
- Space them apart if taking both in the morning to maintain optimal Linzess absorption
Monitor for Overlapping Side Effects
While the medications don't interact, be aware of potential additive effects:
Diarrhea risk: Linzess commonly causes diarrhea (the most frequent side effect), which can sometimes be severe 2. The risk is approximately 3 times higher than placebo, with 83 more cases per 1,000 patients 2. If you develop severe diarrhea while taking both medications, stop Linzess and contact your physician 1.
Sedation: Dramamine causes drowsiness. While this won't interact with Linzess pharmacologically, be cautious with activities requiring alertness.
When to Avoid This Combination
Do not use Linzess if you have:
- Known or suspected mechanical bowel obstruction 2, 1
- Age less than 6 years (contraindicated in children under 2 years due to severe dehydration risk) 1
Clinical Context
The 2023 AGA-ACG guidelines strongly recommend linaclotide for chronic idiopathic constipation and IBS-C in adults who don't respond to over-the-counter agents 2. The medication increases bowel movement frequency (mean difference 1.37-2.22 complete spontaneous bowel movements per week) and improves stool consistency 2, 3.
Bottom line: These medications can be safely combined from a drug interaction standpoint, but monitor for diarrhea as the primary concern with Linzess therapy.